MYRIAD GENETICS, INC. Executive Retention AgreementExecutive Retention Agreement • February 4th, 2015 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Utah
Contract Type FiledFebruary 4th, 2015 Company Industry JurisdictionTHIS EXECUTIVE RETENTION AGREEMENT (this “Agreement”), by and between Myriad Genetics, Inc., a Delaware corporation (the “Company”), and R. Bryan Riggsbee (the “Executive”), is made as of December 18, 2014 (the “Effective Date”).